Physician profile
Hani Razek
NPI 1700886108
$3,252.81
in general payments reported to CMS, 2019-2025
25 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,674 · 2020: $148 · 2021: $110 · 2022: $431 · 2023: $304 · 2024: $234 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,423.85 | 2019-2025 | Watchman, Watchman Flx, Watchman Access System |
| Janssen Pharmaceuticals, INC | $286.12 | 2019-2024 | Xarelto |
| Pfizer INC. | $268.12 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $238.41 | 2019-2025 | |
| Amgen INC. | $157.98 | 2020-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $139.35 | 2019-2024 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.50 | 2020-2023 | Jardiance |
| Baxter Healthcare | $91.75 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $83.27 | 2019-2025 | Evkeeza |
| Philips North America LLC | $73.56 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck4) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.94 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $42.75 | 2019 | |
| Merck Sharp & Dohme LLC | $37.64 | 2023 | Verquvo |
| Irhythm Technologies, INC. | $35.86 | 2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $24.82 | 2023 | Optimizer |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $20.09 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $19.88 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $19.48 | 2022 | |
| Esperion Therapeutics, INC. | $19.20 | 2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $17.77 | 2024 | |
| Amarin Pharma, INC. | $16.07 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $15.97 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $14.93 | 2024 | |
| Arbor Pharmaceuticals, INC. | $14.61 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hani Razek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.